Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin

被引:25
作者
Kaimori, A
Kanto, T
Limn, CK
Komoda, Y
Oki, C
Inoue, M
Miyatake, H
Itose, I
Sakakibara, M
Yakushijin, T
Takehara, T
Matsuura, Y
Hayashi, N
机构
[1] Osaka Univ, Grad Sch Med, Dept Mol Therapeut, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Dendrit Cell Biol & Clin Applicat, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Res Inst Microbial Dis, Res Ctr Emerging Infect Dis, Suita, Osaka, Japan
关键词
hepatitis C virus; envelope proteins; pseudotype virus; dendritic cells; lectin;
D O I
10.1016/j.virol.2004.03.038
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dendritic cells (DC) are the most potent antigen-presenting cells that regulate immune responses. One of the mechanisms for hepatitis C virus (HCV) persistence is the ability of HCV to suppress DC function. Direct HCV infection to blood DC has been implicated for DC dysfunction. To clarify the susceptibility of each DC subset to HCV, we used pseudotype vesicular stomatitis virus (VSV) coated with chimeric HCV envelope glycoproteins (E1 and E2). We demonstrate that pseudotype VSV enters myeloid DC (MDC) but not plasmacytoid DC (PDC). The highest efficiency of pseudotype VSV entry to MDC was observed when MDC were cultured with GM-CSF. Such efficiency decreased when MDC are matured with the treatment of IL-4, CpG oligodeoxynucleotide, or CD40 ligand. Mannan inhibited pseudotype VSV entry to MDC, but Ca2+ chelators failed to do so. These results show that pseudotype VSV possessing HCV-E1 and E2 enters immature MDC through the interaction with lectins in a Ca2+-independent manner. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 35 条
[1]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[2]   Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection [J].
Auffermann-Gratzinger, S ;
Keeffe, EB ;
Levy, S .
BLOOD, 2001, 97 (10) :3171-3176
[3]   Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection [J].
Bain, C ;
Fatmi, A ;
Zoulim, F ;
Zarski, JP ;
Trépo, C ;
Inchauspé, G .
GASTROENTEROLOGY, 2001, 120 (02) :512-524
[4]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[5]   Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection [J].
Corado, J ;
Toro, F ;
Rivera, H ;
Bianco, NE ;
Deibis, L ;
DeSanctis, JB .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :451-457
[6]   BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood [J].
Dzionek, A ;
Fuchs, A ;
Schmidt, P ;
Cremer, S ;
Zysk, M ;
Miltenyi, S ;
Buck, DW ;
Schmitz, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6037-6046
[7]   LACK OF PROTECTIVE IMMUNITY AGAINST REINFECTION WITH HEPATITIS-C VIRUS [J].
FARCI, P ;
ALTER, HJ ;
GOVINDARAJAN, S ;
WONG, DC ;
ENGLE, R ;
LESNIEWSKI, RR ;
MUSHAHWAR, IK ;
DESAI, SM ;
MILLER, RH ;
OGATA, N ;
PURCELL, RH .
SCIENCE, 1992, 258 (5079) :135-140
[8]   C-type lectin receptors on dendritic cells and Langerhans cells [J].
Figdor, CG ;
van Kooyk, Y ;
Adema, GJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :77-84
[9]   Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein [J].
Flint, M ;
Thomas, JM ;
Maidens, CM ;
Shotton, C ;
Levy, S ;
Barclay, WS ;
McKeating, JA .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6782-6790
[10]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597